ME Therapeutics Holdings Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020
Period Ending	Dec '25 Dec 1, 2025	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	2020
Market Capitalization	120	118	69	-	-	-	Upgrade
Market Cap Growth	291.44%	70.86%	-	-	-	-	Upgrade
Enterprise Value	119	117	68	-	-	-	Upgrade
Last Close Price	3.99	4.00	2.75	-	-	-	Upgrade
PB Ratio	79.77	78.74	46.94	-	-	-	Upgrade
P/TBV Ratio	79.77	78.74	46.94	-	-	-	Upgrade
Debt / Equity Ratio	0.05	0.05	-	0.08	-1.46	-3.40	Upgrade
Debt / FCF Ratio	-	-	-	-	-	17.86	Upgrade
Quick Ratio	6.00	6.00	24.05	4.41	0.57	2.27	Upgrade
Current Ratio	6.12	6.12	24.45	4.52	0.59	2.27	Upgrade
Return on Equity (ROE)	-80.11%	-80.11%	-129.52%	-3327.53%	-	-2126.14%	Upgrade
Return on Assets (ROA)	-48.35%	-48.35%	-77.65%	-157.78%	-106.78%	-60.78%	Upgrade
Return on Capital (ROIC)	-52.27%	-52.27%	-84.18%	-195.65%	-183.72%	-82.93%	Upgrade
Return on Capital Employed (ROCE)	-84.30%	-84.30%	-93.10%	-186.70%	212.60%	-167.10%	Upgrade
Earnings Yield	-1.00%	-1.01%	-1.87%	-	-	-	Upgrade
FCF Yield	-0.90%	-0.91%	-0.95%	-	-	-	Upgrade
Buyback Yield / Dilution	-14.17%	-14.17%	-55.90%	-84.08%	-39.53%	-0.07%	Upgrade

Updated Aug 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.